BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, the Wnt/β‐catenin signaling pathway is activated by the BCR‐ABL fusion protein produced by the reciprocal translocation t(9;22) (q34;11), which is found in most cases of chronic myelogenous leukemia (CML).6